Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adverum Biotechnologies Inc (NQ: ADVM )

11.06 -0.09 (-0.81%)
Streaming Delayed Price Updated: 12:03 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,564
Open 11.15
Bid (Size) 11.00 (4)
Ask (Size) 11.08 (2)
Prev. Close 11.15
Today's Range 10.92 - 11.29
52wk Range 0.7100 - 17.65
Shares Outstanding 98,125,866
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... 
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023
ADVM stock results show that Adverum Biotechnologies beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace

Performance

YTD
+1235.59%
+1235.59%
1 Month
+570.30%
+570.30%
3 Month
+1201.33%
+1201.33%
6 Month
+1145.50%
+1145.50%
1 Year
+1102.17%
+1102.17%

More News

Read More
Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop
Via InvestorPlace
Adverum Posts New Data From Wet AMD Gene Therapy Trial
Via Benzinga
Stocks on the Launchpad: The Next 3 Market Sensations
Via InvestorPlace
Unleash Massive Returns With These 3 Top Penny Stocks
Via InvestorPlace
Topics Economy
Exposures Economy
Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Adverum Biotechnologies Stock Is Trading Higher
Via Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today?
Via Benzinga
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
Via ACCESSWIRE
Over $14M Bet On Diversified Healthcare Trust? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
Via Benzinga
Adverum Commences Mid-Stage Chronic Eye Disorder Candidate Study
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
Via Benzinga
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
Via Benzinga
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.